{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:23:17Z","timestamp":1792894997692,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870562"],"award-info":[{"award-number":["81870562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270857"],"award-info":[{"award-number":["82270857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["41906095"],"award-info":[{"award-number":["41906095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ22H070002"],"award-info":[{"award-number":["LZ22H070002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY22D060003"],"award-info":[{"award-number":["LY22D060003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic beta cell dysfunction and activated macrophage infiltration are early features in type 1 diabetes pathogenesis. A tricarboxylic acid cycle metabolite that can strongly activate NF-E2-related factor 2 (Nrf2) in macrophages, itaconate is important in a series of inflammatory-associated diseases via anti-inflammatory and antioxidant properties. However, its role in type 1 diabetes is unclear. We used 4-octyl itaconate (OI), the cell-permeable itaconate derivate, to explore its preventative and therapeutic effects in mouse models of type 1 diabetes and the potential mechanism of macrophage phenotype reprogramming.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The mouse models of streptozotocin (STZ)-induced type 1 diabetes and spontaneous autoimmune diabetes were used to evaluate the preventative and therapeutic effects of OI, which were performed by measuring blood glucose, insulin level, pro- and anti-inflammatory cytokine secretion, histopathology examination, flow cytometry, and islet proteomics. The protective effect and mechanism of OI were examined via peritoneal macrophages isolated from STZ-induced diabetic mice and co-cultured MIN6 cells with OI-pre-treated inflammatory macrophages in vitro. Moreover, the inflammatory status of peripheral blood mononuclear cells (PBMCs) from type 1 diabetes patients was evaluated after OI treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OI ameliorated glycemic deterioration, increased systemic insulin level, and improved glucose metabolism in STZ-induced diabetic mice and non-obese diabetic (NOD) mice. OI intervention significantly restored the islet insulitis and beta cell function. OI did not alter the macrophage count but significantly downregulated the proportion of M1 macrophages. Additionally, OI significantly inhibited MAPK activation in macrophages to attenuate the macrophage inflammatory response, eventually improving beta cell dysfunction in vitro. Furthermore, we detected higher IL-1\u03b2 production upon lipopolysaccharide stimulation in the PBMCs from type 1 diabetes patients, which was attenuated by OI treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results provided the first evidence to date that OI can prevent the progression of glycemic deterioration, excessive inflammation, and beta cell dysfunction predominantly mediated by restricting macrophage M1 polarization in mouse models of type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-023-00626-5","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T09:03:25Z","timestamp":1678784605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["4-Octyl itaconate attenuates glycemic deterioration by regulating macrophage polarization in mouse models of type 1 diabetes"],"prefix":"10.1186","volume":"29","author":[{"given":"Sunyue","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiya","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-6417","authenticated-orcid":false,"given":"Jiaqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"issue":"14","key":"626_CR1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1089\/ars.2017.7243","volume":"29","author":"AR Burg","year":"2018","unstructured":"Burg AR, Tse HM. Redox-sensitive innate immune pathways during macrophage activation in type 1 diabetes. Antioxid Redox Signal. 2018;29(14):1373\u201398.","journal-title":"Antioxid Redox Signal"},{"key":"626_CR2","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","volume":"108","author":"DK Chellappan","year":"2018","unstructured":"Chellappan DK, Sivam NS, Teoh KX, Leong WP, Fui TZ, Chooi K, et al. Gene therapy and type 1 diabetes mellitus. Biomed Pharmacother. 2018;108:1188\u2013200.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"626_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13287-020-01793-6","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen S, Du K, Zou C. Current progress in stem cell therapy for type 1 diabetes mellitus. Stem Cell Res Ther. 2020;11(1):275.","journal-title":"Stem Cell Res Ther"},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmet.2019.11.019","volume":"32","author":"T Cordes","year":"2020","unstructured":"Cordes T, Lucas A, Divakaruni AS, Murphy AN, Cabrales P, Metallo CM. Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab. 2020;32:122\u201335.","journal-title":"Mol Metab"},{"issue":"7","key":"626_CR5","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.4049\/jimmunol.160.7.3585","volume":"160","author":"E Dahl\u00e9n","year":"1998","unstructured":"Dahl\u00e9n E, Dawe K, Ohlsson L, Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol. 1998;160(7):3585\u201393.","journal-title":"J Immunol"},{"issue":"1","key":"626_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/CS20201348","volume":"135","author":"MR Davanso","year":"2021","unstructured":"Davanso MR, Crisma AR, Braga TT, Masi LN, de Amaral CL, Leal VNC, et al. Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3\/iNOS pathway and attenuated by docosahexaenoic acid. Clin Sci (lond). 2021;135(1):19\u201334.","journal-title":"Clin Sci (lond)"},{"key":"626_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/593863","volume":"2011","author":"MM Delmastro","year":"2011","unstructured":"Delmastro MM, Piganelli JD. Oxidative stress and redox modulation potential in type 1 diabetes. Clin Dev Immunol. 2011;2011: 593863.","journal-title":"Clin Dev Immunol"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2018.00270","volume":"9","author":"C Diskin","year":"2018","unstructured":"Diskin C, Palsson-McDermott EM. Metabolic modulation in macrophage effector function. Front Immunol. 2018;9:270.","journal-title":"Front Immunol"},{"issue":"4","key":"626_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4):219\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"626_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/815953","volume":"2012","author":"A Espinoza-Jim\u00e9nez","year":"2012","unstructured":"Espinoza-Jim\u00e9nez A, Pe\u00f3n AN, Terrazas LI. Alternatively activated macrophages in types 1 and 2 diabetes. Mediators Inflamm. 2012;2012: 815953.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"626_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.11.014","volume":"225","author":"FH Galvao Tessaro","year":"2020","unstructured":"Galvao Tessaro FH, Ayala TS, Bella LM, Martins JO. Macrophages from a type 1 diabetes mouse model present dysregulated Pl3K\/AKT, ERK 1\/2 and SAPK\/JNK levels. Immunobiology. 2020;225(2): 151879.","journal-title":"Immunobiology"},{"issue":"2","key":"626_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF00505185","volume":"32","author":"H Hanenberg","year":"1989","unstructured":"Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia. 1989;32(2):126\u201334.","journal-title":"Diabetologia"},{"issue":"5","key":"626_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1172\/JCI116067","volume":"90","author":"A H\u00e4nninen","year":"1992","unstructured":"H\u00e4nninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest. 1992;90(5):1901\u201310.","journal-title":"J Clin Invest"},{"issue":"5","key":"626_CR14","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1172\/JCI116835","volume":"92","author":"N Itoh","year":"1993","unstructured":"Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest. 1993;92(5):2313\u201322.","journal-title":"J Clin Invest"},{"issue":"1","key":"626_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/08916939309004836","volume":"15","author":"A Jansen","year":"1993","unstructured":"Jansen A, Voorbij HA, Jeucken PH, Bruining GJ, Hooijkaas H, Drexhage HA. An immunohistochemical study on organized lymphoid cell infiltrates in fetal and neonatal pancreases. A comparison with similar infiltrates found in the pancreas of a diabetic infant. Autoimmunity. 1993;15(1):31\u20138.","journal-title":"Autoimmunity"},{"issue":"3","key":"626_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00125-013-3125-4","volume":"57","author":"A J\u00f6rns","year":"2014","unstructured":"J\u00f6rns A, Arndt T, MeyerzuVilsendorf A, Klempnauer J, Wedekind D, Hedrich HJ, et al. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia. 2014;57(3):512\u201321.","journal-title":"Diabetologia"},{"issue":"5","key":"626_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/00006676-199209000-00011","volume":"7","author":"V Kolb-Bachofen","year":"1992","unstructured":"Kolb-Bachofen V, Schraermeyer U, Hoppe T, Hanenberg H, Kolb H. Diabetes manifestation in BB rats is preceded by pan-pancreatic presence of activated inflammatory macrophages. Pancreas. 1992;7(5):578\u201384.","journal-title":"Pancreas"},{"issue":"1","key":"626_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24(1):158\u201366.","journal-title":"Cell Metab"},{"key":"626_CR19","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.2147\/DDDT.S280922","volume":"14","author":"Y Li","year":"2020","unstructured":"Li Y, Chen X, Zhang H, Xiao J, Yang C, Chen W, et al. 4-Octyl itaconate alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting oxidative stress and inflammation. Drug Des Devel Ther. 2020;14:5547\u201358.","journal-title":"Drug Des Devel Ther"},{"key":"626_CR20","first-page":"2","volume":"10","author":"S Li","year":"2021","unstructured":"Li S, Vaziri ND, Swentek L, Takasu C, Vo K, Stamos MJ, et al. Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate. Antioxidants (basel). 2021;10:2.","journal-title":"Antioxidants (basel)."},{"issue":"1","key":"626_CR21","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41467-019-13078-5","volume":"10","author":"ST Liao","year":"2019","unstructured":"Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat Commun. 2019;10(1):5091.","journal-title":"Nat Commun"},{"issue":"8","key":"626_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.21037\/atm-21-1448","volume":"9","author":"G Liu","year":"2021","unstructured":"Liu G, Wu Y, Jin S, Sun J, Wan BB, Zhang J, et al. Itaconate ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury through the Nrf2\/ARE pathway. Ann Transl Med. 2021;9(8):712.","journal-title":"Ann Transl Med"},{"issue":"3","key":"626_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1122","volume":"9","author":"J Lu","year":"2020","unstructured":"Lu J, Liu J, Li L, Lan Y, Liang Y. Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets. Clin Transl Immunology. 2020;9(3): e1122.","journal-title":"Clin Transl Immunology"},{"issue":"12","key":"626_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00109-010-0666-6","volume":"88","author":"AJ Meyers","year":"2010","unstructured":"Meyers AJ, Shah RR, Gottlieb PA, Zipris D. Altered Toll-like receptor signaling pathways in human type 1 diabetes. J Mol Med (berl). 2010;88(12):1221\u201331.","journal-title":"J Mol Med (berl)"},{"issue":"7699","key":"626_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113\u20137.","journal-title":"Nature"},{"issue":"4","key":"626_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2018.07.030","volume":"174","author":"MP Murphy","year":"2018","unstructured":"Murphy MP, O\u2019Neill LAJ. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell. 2018;174(4):780\u20134.","journal-title":"Cell"},{"issue":"10","key":"626_CR27","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2337\/diab.38.10.1329","volume":"38","author":"MV Nagy","year":"1989","unstructured":"Nagy MV, Chan EK, Teruya M, Forrest LE, Likhite V, Charles MA. Macrophage-mediated islet cell cytotoxicity in BB rats. Diabetes. 1989;38(10):1329\u201331.","journal-title":"Diabetes"},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2018.12.003","volume":"139","author":"Q Ni","year":"2019","unstructured":"Ni Q, Pham NB, Meng WS, Zhu G, Chen X. Advances in immunotherapy of type I diabetes. Adv Drug Deliv Rev. 2019;139:83\u201391.","journal-title":"Adv Drug Deliv Rev"},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4939-9882-1_9","volume":"2076","author":"JF O'Dowd","year":"2020","unstructured":"O\u2019Dowd JF, Stocker CJ. Isolation and Purification of Rodent Pancreatic Islets of Langerhans. Methods Mol Biol (clifton, NJ). 2020;2076:179\u201384.","journal-title":"Methods Mol Biol (clifton, NJ)"},{"issue":"4","key":"626_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MOT.0000000000000546","volume":"23","author":"AR Pepper","year":"2018","unstructured":"Pepper AR, Bruni A, Shapiro AMJ. Clinical islet transplantation: is the future finally now? Curr Opin Organ Transplant. 2018;23(4):428\u201339.","journal-title":"Curr Opin Organ Transplant"},{"issue":"7","key":"626_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tem.2018.04.008","volume":"29","author":"JM Ratter","year":"2018","unstructured":"Ratter JM, Tack CJ, Netea MG, Stienstra R. Environmental signals influencing myeloid cell metabolism and function in diabetes. Trends Endocrinol Metab. 2018;29(7):468\u201380.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"626_CR32","first-page":"373","volume":"12","author":"C Ridler","year":"2016","unstructured":"Ridler C. Diabetes: Islet transplantation for T1DM. Nat Rev Endocrinol. 2016;12(7):373.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"626_CR33","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/diab.41.11.1380","volume":"41","author":"BO Roep","year":"1992","unstructured":"Roep BO, Kallan AA, De Vries RR. Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes. 1992;41(11):1380\u20134.","journal-title":"Diabetes"},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42255-018-0014-7","volume":"1","author":"DG Ryan","year":"2019","unstructured":"Ryan DG, Murphy MP, Frezza C, Prag HA, Chouchani ET, O\u2019Neill LA, et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab. 2019;1:16\u201333.","journal-title":"Nat Metab"},{"key":"626_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cells8020194","volume":"8","author":"L Subedi","year":"2019","unstructured":"Subedi L, Lee JH, Yumnam S, Ji E, Kim SY. Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK\/AP-1\/NF-kappaB Inhibition and Nrf2\/HO-1 Activation. Cells. 2019;8:2.","journal-title":"Cells"},{"issue":"11","key":"626_CR36","doi-asserted-by":"publisher","first-page":"12929","DOI":"10.1096\/fj.201900887RR","volume":"33","author":"X Sun","year":"2019","unstructured":"Sun X, Zhang B, Pan X, Huang H, Xie Z, Ma Y, et al. Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling. FASEB J. 2019;33(11):12929\u201340.","journal-title":"FASEB J"},{"issue":"2","key":"626_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1159\/000495400","volume":"51","author":"C Tang","year":"2018","unstructured":"Tang C, Wang X, Xie Y, Cai X, Yu N, Hu Y, et al. 4-Octyl itaconate activates Nrf2 signaling to inhibit pro-inflammatory cytokine production in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Cell Physiol Biochem. 2018;51(2):979\u201390.","journal-title":"Cell Physiol Biochem"},{"key":"626_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172989","volume":"873","author":"F Tian","year":"2020","unstructured":"Tian F, Wang Z, He J, Zhang Z, Tan N. 4-Octyl itaconate protects against renal fibrosis via inhibiting TGF-beta\/Smad pathway, autophagy and reducing generation of reactive oxygen species. Eur J Pharmacol. 2020;873: 172989.","journal-title":"Eur J Pharmacol"},{"key":"626_CR39","first-page":"e14354","volume":"5","author":"A Torres","year":"2016","unstructured":"Torres A, Makowski L, Wellen KE. Immunometabolism: Metabolism fine-tunes macrophage activation. Life. 2016;5:e14354.","journal-title":"Life"},{"issue":"9","key":"626_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2337\/diab.37.9.1301","volume":"37","author":"R Walker","year":"1988","unstructured":"Walker R, Bone AJ, Cooke A, Baird JD. Distinct macrophage subpopulations in pancreas of prediabetic BB\/E rats Possible role for macrophages in pathogenesis of IDDM. Diabetes. 1988;37(9):1301\u20134.","journal-title":"Diabetes"},{"key":"626_CR41","doi-asserted-by":"publisher","first-page":"9897442","DOI":"10.1155\/2022\/9897442","volume":"2022","author":"Y Xie","year":"2022","unstructured":"Xie Y, Chen Z, Wu Z. Four-octyl itaconate attenuates UVB-induced melanocytes and keratinocytes apoptosis by Nrf2 activation-dependent ROS inhibition. Oxid Med Cell Longev. 2022;2022:9897442.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"626_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/etm.2020.9573","volume":"21","author":"Y Xin","year":"2021","unstructured":"Xin Y, Zou L, Lang S. 4-Octyl itaconate (4-OI) attenuates lipopolysaccharide-induced acute lung injury by suppressing PI3K\/Akt\/NF-kappaB signaling pathways in mice. Exp Ther Med. 2021;21(2):141.","journal-title":"Exp Ther Med"},{"key":"626_CR43","first-page":"67","volume":"8","author":"Y Yagishita","year":"2019","unstructured":"Yagishita Y, Uruno A, Chartoumpekis DV, Kensler TW, Yamamoto M. Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice. J Endocrinol. 2019;8:67.","journal-title":"J Endocrinol"},{"key":"626_CR44","doi-asserted-by":"publisher","first-page":"5766434","DOI":"10.1155\/2022\/5766434","volume":"2022","author":"W Yang","year":"2022","unstructured":"Yang W, Wang Y, Zhang P, Wang T, Li C, Tong X, et al. Hepatoprotective role of 4-octyl itaconate in concanavalin a-induced autoimmune hepatitis. Mediators Inflamm. 2022;2022:5766434.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"626_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/14756366.2021.1998025","volume":"37","author":"H Yao","year":"2022","unstructured":"Yao H, Zhang W, Yang F, Ai F, Du D, Li Y. Discovery of caffeoylisocitric acid as a Keap1-dependent Nrf2 activator and its effects in mesangial cells under high glucose. J Enzyme Inhib Med Chem. 2022;37(1):178\u201388.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"626_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.31147","volume":"72","author":"Z Yi","year":"2020","unstructured":"Yi Z, Deng M, Scott MJ, Fu G, Loughran PA, Lei Z, et al. Immune-Responsive Gene 1\/Itaconate Activates Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocytes to Protect Against Liver Ischemia-Reperfusion Injury. Hepatology. 2020;72(4):1394\u2013411.","journal-title":"Hepatology"},{"key":"626_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbrc.2022.03.106","volume":"606","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, Wang Z, Bao Y, Liu W, Hong L. OI inhibits development of ovarian cancer by blocking crosstalk between cancer cells and macrophages via HIF-1alpha pathway. Biochem Biophys Res Commun. 2022;606:142\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"626_CR48","first-page":"24","volume":"3","author":"S Zhang","year":"2009","unstructured":"Zhang S, Zhong J, Yang P, Gong F, Wang CY. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol. 2009;3(1):24\u201338.","journal-title":"Int J Clin Exp Pathol"},{"issue":"24","key":"626_CR49","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.7150\/thno.48264","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Han X, Yang L, Fu J, Sun C, Huang S, et al. Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus. Theranostics. 2020;10(24):10908\u201324.","journal-title":"Theranostics"},{"key":"626_CR50","unstructured":"Lucier J, Weinstock RS. Diabetes Mellitus Type 1. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC.; 2022."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00626-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T10:12:34Z","timestamp":1678788754000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00626-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00626-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2355930\/v1","asserted-by":"object"}]},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Sir Run Run Shaw Hospital of Zhejiang University ethics committee approved the present study under number 2022-530-01. All procedures were performed according to institutional and national research committee ethical standards. All participants signed informed consent letters before their inclusion. The animal experimental protocols were approved by the Zhejiang Chinese Medical University Ethic Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}